Skip to content

A COMPARATIVE STUDY on two different type of virechana methods IN THE MANAGEMENT OF EKAKUSTHA(PSORIASIS).

A COMPARATIVE STUDY OFSRANSANA TYPE OF VIRECHANA AND RECHANA TYPE OF VIRECHANA IN THE MANAGEMENT OF EKAKUSTHA(PSORIASIS).

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/031698
Enrollment
30
Registered
2021-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L988- Other specified disorders of the skin and subcutaneous tissue

Interventions

Intervention1: TRIVRITTA MOOLA TVAK CHURNA: dose will be 5-7 grams according to kostha frequency route of administration will be once, orally and duration of therapy will be one day Control Interven

Sponsors

j s ayurvedamahavidhyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of both genders will be included. As per sign & symptoms of kustha described in classical Ayurvedic text and modern medical view. Patients suitable for Virechana karma.

Exclusion criteria

Exclusion criteria: Virechana Ayogya as per classical text. Patients suffering from severe systemic illness like uncontrolled diabetes mellitus,hypertension,tuberculosis,carcinoma etc.

Design outcomes

Primary

MeasureTime frame
ïÆ?Ë? There will be significant difference between Sransrana type of Virechana and Rechana type of virechana in the management of psoriasis based on PASI score.Timepoint: ïÆ?Ë? 45 days ïÆ?Ë? There willbe significant difference between Sransrana type of Virechana and Rechana type of virechana in the management of psoriasis 45 days

Secondary

MeasureTime frame
remission in sign and sympton of psoriasisTimepoint: 45 days

Countries

India

Contacts

Public Contactdr anish tiwari

j.s.ayurved mahavidyalaya

vd.jaimin@gmail.com9427859535

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026